all report title image

LUNG CANCER DIAGNOSTIC AND SCREENING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Lung Cancer Diagnostic and Screening Market, By Test Type (Biomarkers Test (EGFR Mutation Test, KRAS Mutation Test, ALK Test, HER2 Test, Others) Imaging Test (Computed Tomography (CT) scan, Positron Emission Tomography (PET) scan, Chest X-Ray, Others), Biopsy), By Cancer Type (Non-small cell lung cancer, Small Cell Lung CancerNeurosurgery), By End User (Hospital Associated Labs, Independent Diagnostic Laboratories, Cancer Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In: 29 Apr, 2026
  • Code: CMI4434
  • Page number: 180
  • Formats:   Excel and PDF
  • Industry: Clinical Diagnostic
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033

Table of Contents (Version-2026)

  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Test Type
      • Market Snippet, By Cancer Type
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Test Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. Global Lung Cancer Diagnostic and Screening Market, By Test Type, 2021–2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Biomarkers Test
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
        • EGFR Mutation Test
        • KRAS Mutation Test
        • ALK Test
        • HER2 Test
        • Others
    • Imaging Test
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
        • Computed Tomography (CT) scan
        • Positron Emission Tomography (PET) scan
        • Chest X-Ray
        • Others
    • Biopsy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
  5. Global Lung Cancer Diagnostic and Screening Market, By Cancer Type, 2021–2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Non-small cell lung cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
    • Small Cell Lung Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
  6. Global Lung Cancer Diagnostic and Screening Market, By End User, 2021–2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Hospital Associated Labs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
    • Independent Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
    • Cancer Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
  7. Global Lung Cancer Diagnostic and Screening Market, By Region, 2021–2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Company Profiles
      • Abbott
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Amgen Inc.,
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Illumina, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Lepu Medical Technology(Beijing)Co.,Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • AstraZeneca
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • F. Hoffmann-La Roche Ltd
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Laboratory Corporation of America Holdings.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Agilent Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • QIAGEN
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Quest Diagnostics Incorporated.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • NeoGenomics Laboratories.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Myriad Genetics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • GRAIL, LLC.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • DELFI Diagnostics
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 31 figures on “Global Lung Cancer Diagnostic and Screening Market” – Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.